KINS · Kingstone Companies, Inc. · Insider Trading

Shares were withheld from vested stock grant to pay the associated withholding taxes.

Includes 34,551 shares received pursuant to unvested restricted stock grants. The shares vest to the extent of 1,042 shares on March 3, 2027, 10,822 shares on August 25, 2027, 1,042 shares on March 3, 2028 and 21,645 shares on August 25, 2028.

Shares were withheld from vested stock grant to pay the associated withholding taxes.

Includes 12,727 shares received pursuant to unvested restricted stock grants. Such shares vest to the extent of 6,520 shares on March 3, 2027, 3,333 shares on June 18, 2027 and 2,874 shares on March 3, 2028.

This transaction was executed in multiple trades at prices ranging from $14.97 to $15.00 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.

Includes 3,149 unvested shares received as director fees. Such shares vest on January 2, 2027, subject to earlier vesting under certain circumstances.

Includes 3,149 unvested shares received as director fees. Such shares vest on January 2, 2027, subject to earlier vesting under certain circumstances.

This transaction was executed in multiple trades at prices ranging from $14.15 to $14.60 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.

Includes 3,149 unvested shares received as director fees. Such shares vest on January 2, 2027, subject to earlier vesting under certain circumstances.

This transaction was executed in multiple trades at prices ranging from $13.97 to $14.75 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.

Includes 3,149 unvested shares received as director fees. Such shares vest on January 2, 2027, subject to earlier vesting under certain circumstances.

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2025.

Includes 3,149 unvested shares received as director fees. Such shares vest on January 2, 2027, subject to earlier vesting under certain circumstances.

Shares were withheld from vested stock grant to pay the associated withholding taxes.

Includes 14,055 shares received pursuant to unvested restricted stock grants. Such shares vest to the extent of 2,028 shares on March 3, 2027, 5,000 shares on April 15, 2027, 2,027 shares on March 3, 2028 and 5,000 shares on April 15, 2028.

Shares received pursuant to restricted stock grant.

Includes 16,060 shares received pursuant to unvested restricted stock grants. Such shares vest to the extent of 3,333 shares on June 18, 2026, 6,520 shares on March 3, 2027, 3,333 shares on June 18, 2027 and 2,874 shares on March 3, 2028.

Shares received pursuant to restricted stock grant.

Includes 19,055 shares received pursuant to unvested restricted stock grants. Such shares vest to the extent of 5,000 shares on April 15, 2026, 2,028 shares on March 3, 2027, 5,000 shares on April 15, 2027, 2,027 shares on March 3, 2028 and 5,000 shares on April 15, 2028.

The option vests and becomes exercisable to the extent of 3,333 shares on each of January 5, 2026 and January 5, 2027.

Shares were withheld from vested stock grant to pay the associated withholding taxes.

Includes 16,060 shares received pursuant to unvested restricted stock grants. Such shares vest to the extent of 3,333 shares on June 18, 2026, 6,520 shares on March 3, 2027, 3,333 shares on June 18, 2027 and 2,874 shares on March 3, 2028.

Shares received pursuant to restricted stock grant.

Includes 45,374 shares received pursuant to unvested restricted stock grants. The shares vest to the extent of 10,823 shares on August 25, 2026, 1,042 shares on March 3, 2027, 10,822 shares on August 25, 2027, 1,042 shares on March 3, 2028 and 21,645 shares on August 25, 2028.

Includes 16,060 shares received pursuant to unvested restricted stock grants. Such shares vest to the extent of 3,333 shares on June 18, 2026, 6,520 shares on March 3, 2027, 3,333 shares on June 18, 2027 and 2,874 shares on March 3, 2028.

Shares were withheld from vested stock grant to pay the associated withholding taxes.

Includes 45,374 shares received pursuant to unvested restricted stock grants. The shares vest to the extent of 10,823 shares on August 25, 2026, 1,042 shares on March 3, 2027, 10,822 shares on August 25, 2027, 1,042 shares on March 3, 2028 and 21,645 shares on August 25, 2028.

Shares were withheld from vested stock grant to pay the associated withholding taxes.

Includes 19,055 shares received pursuant to unvested restricted stock grants. Such shares vest to the extent of 5,000 shares on April 15, 2026, 2,028 shares on March 3, 2027, 5,000 shares on April 15, 2027, 2,027 shares on March 3, 2028 and 5,000 shares on April 15, 2028.

Shares received pursuant to restricted stock grant. Such shares vest on January 9, 2027.

Includes 60,000 shares received pursuant to unvested restricted stock grants. Such shares vest to the extent of 20,000 shares on December 31, 2026 and 40,000 shares on January 9, 2027.

Shares were withheld from vested stock grant to pay associated withholding taxes.

Includes 20,000 shares received pursuant to unvested restricted stock grant. Such shares vest on December 31, 2026.

Received as director fees. Vests on January 2, 2027, subject to earlier vesting under certain circumstances.

Includes 3,149 unvested shares received as director fees. Such shares vest on January 2, 2027, subject to earlier vesting under certain circumstances.

Received as director fees. Vests on January 2, 2027, subject to earlier vesting under certain circumstances.

Includes 7,011 unvested shares received as director fees. Such shares vest on January 2, 2027, subject to earlier vesting under certain circumstances.

Received as director fees. Vests on January 2, 2027, subject to earlier vesting under certain circumstances.

Includes 7,011 unvested shares received as director fees. Such shares vest on January 2, 2027, subject to earlier vesting under certain circumstances.

Funds managed by Angel Oak Capital Advisors ("AOCA") hold 108,249 shares of common stock of the Issuer. Mr. Singh serves as Group Chief Financial Officer and Head of Corporate Development of Angel Oak Companies, which is the parent of AOCA. Mr. Singh disclaims beneficial ownership of such securities.

Received as director fees. Vests on January 2, 2027, subject to earlier vesting under certain circumstances.

Includes 3,149 unvested shares received as director fees. Such shares vest on January 2, 2027, subject to earlier vesting under certain circumstances.

Received as director fees. Vests on January 2, 2027, subject to earlier vesting under certain circumstances.

Includes 3,149 unvested shares received as director fees. Such shares vest on January 2, 2027, subject to earlier vesting under certain circumstances.

The shares were acquired pursuant to the Company's Employee Stock Purchase Plan.

Includes 40,000 shares received pursuant to unvested restricted stock grant. Such shares vest to the extent of 20,000 shares on January 2, 2026 and 20,000 shares on December 31, 2026.

Shares received pursuant to restricted stock grant.

The shares vest to the extent of 10,823 shares on August 25, 2026, 10,822 shares on August 25, 2027 and 21,645 shares on August 25, 2028.

Received as director fees.

Represents unvested shares received as director fees. Such shares vest on January 2, 2026, subject to earlier vesting under certain circumstances.

Shares received pursuant to restricted stock grant.

Includes 13,956 shares received pursuant to unvested restricted stock grant. Such shares vest to the extent of 3,645 shares on March 3, 2026, 3,333 shares on June 18, 2026, 3,645 shares on March 3, 2027 and 3,333 shares on June 18, 2027.

This transaction was executed in multiple trades at prices ranging from $16.65 to $16.85 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.

Includes 3,489 unvested shares received as director fees. Such shares vest on January 2, 2026, subject to earlier vesting under certain circumstances.

Amendment filed to correct transaction code.

This transaction was executed in multiple trades at prices ranging from $15.79 to $16.01 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.

This transaction was executed in multiple trades at prices ranging from $15.90 to $16.35 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.

Includes 3,489 unvested shares received as director fees. Such shares vest on January 2, 2026, subject to earlier vesting under certain circumstances.

Includes 3,489 unvested shares received as director fees. Such shares vest on January 2, 2026, subject to earlier vesting under certain circumstances.

Includes 3,489 unvested shares received as director fees. Such shares vest on January 2, 2026, subject to earlier vesting under certain circumstances.

Shares received pursuant to restricted stock grant.

Includes 15,000 shares received pursuant to unvested restricted stock grant. Such shares vest to the extent of 5,000 shares on each of April 15, 2026, April 15, 2027 and April 15, 2028.

Shares received pursuant to restricted stock grant.

Includes 7,290 shares received pursuant to unvested restricted stock grant. Such shares vest to the extent of 3,645 shares on each of March 3, 2026 and March 3, 2027.

Shares received pursuant to restricted stock grant.

Includes 10,703 unvested shares received pursuant to restricted stock grants. Such shares vest to the extent of 4,845 shares on January 17, 2026 and 2,929 shares on each of March 3, 2026 and March 3, 2027.

The option vests and becomes exercisable to the extent of 3,334 shares on January 5, 2025 and 3,333 shares on each of January 5, 2026 and January 5, 2027.

Shares were withheld from vested stock grant to pay associated withholding taxes.

Includes 4,845 unvested shares received pursuant to restricted stock grant. Such shares vest on January 17, 2026.

Shares were withheld from vested stock grant to pay associated withholding taxes.

Includes 40,000 shares received pursuant to unvested restricted stock grant. Such shares vest to the extent of 20,000 shares on each of January 2, 2026 and December 31, 2026.

Shares were withheld from vested stock grant to pay associated withholding taxes.

Includes 10,000 shares received pursuant to unvested restricted stock grant. Such shares vest on January 3, 2025.

Received as director fees. Vests on January 2, 2026, subject to earlier vesting under certain circumstances.

Includes 3,489 unvested shares received as director fees. Such shares vest on January 2, 2026, subject to earlier vesting under certain circumstances.

Shares received pursuant to restricted stock grant. Such shares vest to the extent of 20,000 shares on each of January 2, 2026 and December 31, 2026.

Includes 50,000 shares received pursuant to unvested restricted stock grants. Such shares vest to the extent of 10,000 shares on January 3, 2025 and 20,000 shares on each of January 2, 2026 and December 31, 2026.

Received as director fees. Vests on January 2, 2026, subject to earlier vesting under certain circumstances.

Includes 3,489 unvested shares received as director fees. Such shares vest on January 2, 2026, subject to earlier vesting under certain circumstances.

Received as director fees. Vests on January 2, 2026, subject to earlier vesting under certain circumstances.

Includes 3,489 unvested shares received as director fees. Such shares vest on January 2, 2026, subject to earlier vesting under certain circumstances.

Received as director fees. Vests on January 2, 2026, subject to earlier vesting under certain circumstances.

Includes 3,489 unvested shares received as director fees. Such shares vest on January 2, 2026, subject to earlier vesting under certain circumstances.

Received as director fees. Vests on January 2, 2026, subject to earlier vesting under certain circumstances.

Includes 3,489 unvested shares received as director fees. Such shares vest on January 2, 2026, subject to earlier vesting under certain circumstances.

Received as director fees. Vests on January 2, 2026, subject to earlier vesting under certain circumstances.

Includes 3,489 unvested shares received as director fees. Such shares vest on January 2, 2026, subject to earlier vesting under certain circumstances.

Funds managed by Angel Oak Capital Advisors ("AOCA") hold 243,856 shares of common stock of the Issuer and warrants for the purchase of 275,669 shares of common stock of the Issuer. Mr. Singh serves as Group Chief Financial Officer and Head of Corporate Development of Angel Oak Companies, which is the parent of AOCA. Mr. Singh disclaims beneficial ownership of such securities.

Shares were withheld from vested stock grant to pay associated withholding taxes.

Includes 10,000 shares received pursuant to unvested restricted stock grants. Such shares vest on January 3, 2025.

Shares were withheld from vested stock grant to pay associated withholding taxes.

Includes 124,640 shares received pursuant to unvested restricted stock grants. Such shares vest to the extent of 50,555 shares on December 31, 2024, 64,085 shares on January 2, 2025 and 10,000 shares on January 3, 2025.

This transaction was executed in multiple trades at prices ranging from $16.05 to $16.29 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.

Includes 24,883 unvested shares received as director fees. Such shares vest on January 2, 2025, subject to earlier vesting under certain circumstances.